Sort
23,748 grants matching “melanoma”
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2025 · OD
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2023 · OD
Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient Cancer
$418,750Susan E Gueble · Yale University · DP5 · FY2024 · OD
Targeting the Rac1 signaling pathway in malignant melanoma
$418,613Jonathan D. Chernoff · Research Inst Of Fox Chase Can Ctr · R01 · FY2018 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$418,557Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$418,528Zhen Gu · University Of California Los Angeles · R01 · FY2019 · CA
Cellular and molecular regulators of melanocyte regeneration
$418,399Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AR
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$418,234Melody A Swartz · University Of Chicago · R01 · FY2024 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$418,140Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Molecular Epidemiology of Non-Melanoma Skin Cancer
$418,087Heather Nelson · University Of Minnesota · R01 · FY2010 · CA
COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS
$418,077Katheryn A Resing · University Of Colorado · R01 · FY2006 · CA
Transport Oncophysics Core
$418,062Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA
A Regulatory Triad: IL35, Tregs and iTr35
$418,000Dario Aa Vignali · St. Jude Children'S Research Hospital · R01 · FY2012 · AI
A pooling project on alcohol use and risk of cancers with inconsistent prior evidence, with an emphasis in non-smokers.
$417,778Pietro Ferrari · International Agency For Res On Cancer · R01 · FY2018 · AA
Control of Alphavirus Replication in the Nervous System
$417,718Diane E Griffin · Johns Hopkins University · R01 · FY2009 · NS
COMPUTATIONAL TOOLS FOR CANCER PROTEOMICS
$417,645Katheryn A Resing · University Of Colorado · R01 · FY2007 · CA
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$417,630Jin-Ming Yang · University Of Kentucky · R01 · FY2018 · CA
TARGETING PALMITOYL ACYLTRANSFERASES IN MUTANT NRAS-DRIVEN MELANOMA
$417,600The General Hospital Corporation · · FY2013 · Department of Defense
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$417,457Andrea Facciabene · University Of Pennsylvania · R01 · FY2016 · CA
How Circulating Melanoma Cells Usurp the Leukocyte Transmigration Mechanism for Successful Metastasis
$417,401William A Muller · Northwestern University At Chicago · R01 · FY2023 · CA
How Circulating Melanoma Cells Usurp the Leukocyte Transmigration Mechanism for Successful Metastasis
$417,398William A Muller · Northwestern University At Chicago · R01 · FY2022 · CA
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In Situ
$417,345David J Mooney · Harvard University · R01 · FY2022 · CA
Training Program in Cancer Immunobiology
$417,339Bradley W McIntyre · University Of Tx Md Anderson Can Ctr · T32 · FY2011 · CA
REGULATION AND ADAPTIVE MECHANISMS OF ONCOGENIC RAS/ERK SIGNALING
$417,319Poulikos I Poulikakos · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Project 3: Integrative Computational Analysis of Tumor-Mediated Immunosuppression
$417,076Sylvia Katina Plevritis · Stanford University · U54 · FY2016 · CA